Compugen (CGEN) Interest Coverage Ratio Growth (1y) (2012 - 2025)
Compugen (CGEN) Interest Coverage Ratio Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 787.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -100.36% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 73.00% |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,577.35% |
| Dec 31, 2024 | -100.72% |
| Dec 31, 2023 | 28,603.03% |
| Dec 31, 2022 | 98.75% |
| Dec 31, 2021 | -992.42% |
| Dec 31, 2020 | 49.62% |
| Dec 31, 2019 | -242.86% |
| Dec 31, 2018 | 4.20% |
| Dec 31, 2017 | 4.68% |
| Dec 31, 2016 | -1,032.16% |
| Dec 31, 2015 | 34.32% |
| Dec 31, 2014 | 71.07% |
| Dec 31, 2013 | -20,233.12% |
| Dec 31, 2012 | 99.51% |